186 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Rank Status Study
21 Recruiting Physiopathology Study of Auto-immune Thrombopenia. Multicentre, Open, Controlled Study
Condition: Idiopathic Thrombopenic Purpura (ITP)
Interventions: Other: Blood samples;   Other: Spleen samples
22 Not yet recruiting Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
Condition: Immune Thrombocytopenic Purpura
Intervention: Drug: BMS-986004
23 Unknown  Helicobacter Pylori Immune Thrombocytopenic Purpura
Condition: Immune Thrombocytopenic Purpura
Intervention:
24 Recruiting Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
Condition: Immune Thrombocytopenia
Intervention:
25 Not yet recruiting A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Fostamatinib Disodium;   Drug: Placebo
26 Recruiting Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Conditions: Anemia;   Hematopoietic/Lymphoid Cancer;   Lymphopenia;   Neutropenia;   Thrombocytopenia
Interventions: Biological: Allogeneic hematopoietic stem cell transplantation;   Biological: Peripheral blood stem cell transplantation;   Procedure: Management of therapy complications
27 Recruiting IGIV Study for Chronic ITP Patients Ages 3-70
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Biological: IGIV3I Grifols 10%
28 Not yet recruiting MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP
Conditions: Immune Thrombocytopenic Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Blisibimod;   Other: Placebo
29 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
30 Recruiting Thromboelastography, Cytokines and HLA-antibodies in Patients With Chemotherapy-induced Thrombocytopenia
Conditions: Bone Marrow Diseases;   Lymphoma
Intervention:
31 Recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
32 Unknown  Influence of Extracorporeal Circulation During Cardiac Surgery on the Development of Postoperative Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Cardiac Surgery
Intervention:
33 Recruiting Eltrombopag for Management of Thrombocytopenia
Condition: Leukemia
Intervention: Drug: Eltrombopag
34 Recruiting Myeloproliferative Neoplasms: an In-depth Case-control Study
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Primary Myelofibrosis
Interventions: Other: Methodological pens;   Other: Methodological compensation;   Other: Methodological trolley tokens
35 Recruiting Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
Conditions: Immune Thrombocytopenia;   Chemotherapy Induced Thrombocytopenia;   Myelodysplasia Related Thrombocytopenia;   Aplastic Anaemia Related Thrombocytopenia
Intervention: Other: Full blood count with extended platelet parameters
36 Recruiting Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag olamine;   Other: Placebo
37 Recruiting Ruxolitinib Prior to Transplant in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis;   Post Polycythemia Vera Myelofibrosis;   Post Essential Thrombocythemia Myelofibrosis
Intervention: Drug: Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
38 Recruiting The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenia
Intervention:
39 Recruiting The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome
Interventions: Drug: Oral Azacitidine;   Drug: Placebo
40 Recruiting High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP
Condition: Immune Thrombocytopenia
Interventions: Drug: Dexamethasone;   Drug: Thalidomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years